---
$id: https://graph.org.ai/products/commodity/51272111
$type: Product
source: UNSPSC
code: "51272111"
title: "Amethocaine or tetracaine"
class: "51272100"
classTitle: "Anaesthetic benzoates"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Amethocaine or tetracaine

**UNSPSC Code**: 51272111
**Class**: [Anaesthetic benzoates](Anaesthetic benzoates.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C15H24N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0619F35CGV, chemically known as p-(butylamino)benzoic acid, 2-(dimethylamino)ethyl ester but generally known as tetracaine, which bears US NIH Compound Identifier 5411. European Medicines Agency schedules Tetracaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10940MIG. The term TETRACAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules tetracaine in its Anatomical Therapeutic Chemical (ATC) Classification. TETRACAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Amethocaine or tetracaine bears US NLM identifiers UMLS ID C0039629 and NCI Concept Code C66590. SMILES: O(CCN(C)C)C(=O)C1CCC(NCCCC)CC1.

